1
|
Ferlay J, Autire P, Boniol M, Heanue M,
Colombet M and Boyle P: Estimates of the cancer incidence and
mortality in Europe in 2006. Ann Oncol. 18:581–592. 2007.
View Article : Google Scholar : PubMed/NCBI
|
2
|
United States Cancer Statistics. Top Ten
Cancer. 2006
|
3
|
Landi MT, Consonni D, Rotunno M, et al:
Environment and Genetics in Lung cancer Etiology (EAGLE) study: an
integrative population-based case-control study of lung cancer. BMC
Public Health. 8:203–213. 2008. View Article : Google Scholar : PubMed/NCBI
|
4
|
Miura K, Bowman ED, Simon R, et al: Laser
capture microdissection and microarray expression analysis of lung
adenocarcinoma reveals tobacco smoking- and prognosis-related
molecular profiles. Cancer Res. 62:3244–3250. 2002.
|
5
|
Devesa SS, Bray F, Vizcaino AP and Parkin
DM: International lung cancer trends by histologic type:
male:female differences diminishing and adeno-carcinoma rates
rising. Int J Cancer. 117:294–299. 2005. View Article : Google Scholar : PubMed/NCBI
|
6
|
Mountain CF: Revisions in the
international system for staging lung cancer. Chest. 111:1710–1717.
1997. View Article : Google Scholar : PubMed/NCBI
|
7
|
Ramaswamy S, Ross KN, Lander ES and Golub
TR: A molecular signature of metastasis in primary solid tumors.
Nat Genet. 33:49–54. 2003. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Garber ME, Troyanskaya OG, Schluens K, et
al: Diversity of gene expression in adenocarcinoma of the lung.
Proc Natl Acad Sci USA. 98:13784–13789. 2001. View Article : Google Scholar : PubMed/NCBI
|
9
|
Bhattacharjee A, Richards WG, Staunton J,
et al: Classification of human lung carcinomas by mRNA expression
profiling reveals distinct adeno-carcinoma subclasses. Proc Natl
Acad Sci USA. 98:13790–13795. 2001. View Article : Google Scholar : PubMed/NCBI
|
10
|
Beer DG, Kardia SL, Huang CC, et al:
Gene-expression profiles predict survival of patients with lung
adenocarcinoma. Nat Med. 8:816–824. 2002.PubMed/NCBI
|
11
|
Endoh H, Tomida S, Yatabe Y, et al:
Prognostic model of pulmonary adenocarcinoma by expression
profiling of eight genes as determined by quantitative real-time
reverse transcriptase polymerase chain reaction. J Clin Oncol.
22:811–819. 2004. View Article : Google Scholar
|
12
|
Xi L, Lyons-Weiler J, Coello MC, et al:
Prediction of lymph node metastasis by analysis of gene expression
profiles in primary lung adenocarcinomas. Clin Cancer Res.
11:4128–4135. 2005. View Article : Google Scholar : PubMed/NCBI
|
13
|
Meyerson M and Carbone D: Genomic and
proteomic profiling of lung cancers: lung cancer classification in
the age of targeted therapy. J Clin Oncol. 23:3219–3226. 2005.
View Article : Google Scholar : PubMed/NCBI
|
14
|
He P, Varticovski L, Bowman ED, et al:
Identification of carboxypeptidase E and gamma-glutamyl hydrolase
as biomarkers for pulmonary neuro-endocrine tumors by cDNA
microarray. Hum Pathol. 35:1169–1209. 2004.PubMed/NCBI
|
15
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Potti A, Mukherjee S, Petersen R, et al: A
genomic strategy to refine prognosis in early-stage non-small-cell
lung cancer. New England J Med. 355:570–580. 2006. View Article : Google Scholar
|
17
|
Reddy SP: The antioxidant response element
and oxidative stress modifiers in airway diseases. Curr Mol Med.
8:376–383. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Walser T, Cui X, Yanagawa J, Lee JM,
Heinrich E, Lee G, Sharma S and Dubinett SM: Smoking and lung
cancer: the role of inflammation. Proc Am Thorac Soc. 5:811–815.
2008. View Article : Google Scholar : PubMed/NCBI
|
19
|
Giri SN and Hollinger MA: Effect of
cadmium on lung lysosomal enzymes in vitro. Arch Toxicol.
69:341–345. 1995. View Article : Google Scholar : PubMed/NCBI
|
20
|
Shimoi K, Saka N, Nozawa R, et al:
Deglucuronidation of a flavonoid, luteolin monglucuronide, during
inflammation. Drug Metab Disp. 29:1521–1524. 2001.PubMed/NCBI
|
21
|
Marshall T, Shult P and Busse WW: Release
of lysosomal enzyme β-glucuronidase from isolated human
eosinophils. J Allergy Clin Immunol. 82:550–555. 1988.
|
22
|
Cobben NA, Drent M, De Vries J, Wouters
EF, van Dieijen-Visser MP and Henderson RF: Serum β-glucuronidase
activity in a population of ex-coalminers. Clin Biochem.
32:659–664. 1999.
|
23
|
DiMatteo M, Antonini JM, van Dyke K and
Reasor MJ: Characteristics of the acute phase pulmonary response to
silica in rats. J Toxicol Environ Health. 47:93–108. 1996.
View Article : Google Scholar : PubMed/NCBI
|
24
|
DiMatteo M and Reasor MJ: Modulation of
silica-induced pulmonary toxicity by dexamethasone-containing
liposomes. Toxicol Appl Pharmacol. 142:411–421. 1997. View Article : Google Scholar : PubMed/NCBI
|
25
|
Hirano S, Shimada T, Osugi J, Kodama N and
Suzuki KT: Pulmonary clearance and inflammatory potence
intratracheally instilled or acutely inhaled nickel sulfate in
rats. Arch Toxicol. 68:548–554. 1994. View Article : Google Scholar : PubMed/NCBI
|
26
|
Matulionis D and Traurig HH: In situ
response of lung macrophages and hydrolase activities to cigarette
smoke. Lab Invest. 37:314–326. 1977.PubMed/NCBI
|
27
|
Pappas P, Sotiropoulou M, Karamanakos P,
et al: Acute-phase response to benzo[a]pyrene and induction of rat
ALDH3A1. Chem Bil Interac. 144:55–62. 2003.
|
28
|
Kong LY, Luster MI, Dixon D, O'Grady J and
Rosenthal GJ: Inhibition of lung immunity after tracheal
instillation of benzo[a]pyrene. Am J Resp Cit Care Med.
150:1123–1129. 1994.PubMed/NCBI
|
29
|
Levy G and Conchi J: β-Glucuronidase and
the hydrolysis of glucuronides. Glucuronic Acid: Free and Combined.
Academic Press; New York: pp. 301–364. 1966
|
30
|
Marsh CA: Metabolism of D-glucarolactone
in mammalian systems. Identification of D-glucaric acid as a normal
constituent of urine. Biochem J. 86:77–86. 1963.PubMed/NCBI
|
31
|
Matsui M, Fukuo A, Watanabe Y, Wanibe T
and Okada M: Studies on the glucaric acid pathway in the metabolism
of D-glucuronic acid in mammals. IV. Fluorometric method for the
determination of D-glucaric acid in serum. Chem Phar Bull.
20:845–848. 1972. View Article : Google Scholar : PubMed/NCBI
|
32
|
Blumenthal HJ, Lucuta VL and Blumenthal
DC: Specific enzymic assay for D-glucarate in human serum. Anal
Biochem. 185:286–293. 1990. View Article : Google Scholar : PubMed/NCBI
|
33
|
Colombi A, Maroni M, Antonini C, Fait A,
Zocchetti C and Foa V: Influence of sex, age and smoking habits on
the urinary excretion of D-glucaric acid. Clin Chim Acta.
128:349–358. 1983. View Article : Google Scholar : PubMed/NCBI
|
34
|
Mocarelli P, Brambilla P, Colombo L, et
al: A new method for D-glucaric acid excretion measurement that is
suitable for automated instruments. Clin Chem. 34:2238–2290.
1988.PubMed/NCBI
|
35
|
Batt HM and Siest G: Laboratory tests as
indirect indications of the activity of drug metabolizing enzymes
use of glucaric acid and gamma-glutamyl-transpeptidase. Dev Clin
Biochem. 2:178–192. 1980.
|
36
|
Yokoyama M, Matsuoka S and Wakui A:
Activation of tegafur and urinary excretion of D-glucaric acid in
tumor-bearing hosts. In: Recent Adv Chemother, Proc Int Congr
Chemother 14th. Univ Tokyo Press; Tokyo: pp. 113–115. 1985
|
37
|
Dohrmann RE: β-Glucuronidase.
Springer-Verlag; Berlin: 1969
|
38
|
Masaki H: Metabolic pathway of dermal
D-glucaric acid synthesis from D-glucuronolactone. D-Glucaric acid
and D-glucuronolactone dehydrogenase in human skin. β-Gucuronidase
feedback mechanism. Nippon Hifuka Gakkai Zashi. 82:151–158
Chem Abstr. 78:2709b–27062u. 1972.
|
39
|
Dutton GJ: Glucuronidation of Drugs and
Other Compounds. CRC Press; Boca Raton, FL: 1980
|
40
|
Clark AG, Fischer FJ, Milburn P, Smith RL
and Williams RL: The role of gut flora in the enterohepatic
circulation of stilboestrol in the rat. Biochem J. 112:17–18.
1988.PubMed/NCBI
|
41
|
Walaszek Z: Potential use of D-glucaric
acid derivatives in cancer prevention. Cancer Lett. 54:1–8. 1990.
View Article : Google Scholar : PubMed/NCBI
|
42
|
Walaszek Z: Chemopreventive properties of
D-glucaric acid derivatives. Cancer Bull. 45:453–457. 1993.
|
43
|
Yoshimi N, Walaszek Z, Mori H, Hanausek M,
Szemraj J and Slaga TJ: Inhibition of azoxymethane-induced rat
colon carcinogenesis by potassium hydrogen D-glucarate. Int J
Oncol. 16:43–48. 2000.PubMed/NCBI
|
44
|
Walaszek Z, Szemraj J, Hanausek M, Adams
AK and Sherman U: D-Glucaric acid content of various fruits and
vegetables and cholesterol lowering effects of dietary D-glucarate
in the rat. Nutr Res. 16:673–682. 1996. View Article : Google Scholar
|
45
|
Zoltaszek R, Hanausek M, Kiliańska ZM and
Walaszek Z: The biological role of D-glucaric acid and its
derivatives potential use in medicine. Adv Hyg Exptl Med.
62:451–462. 2008.PubMed/NCBI
|
46
|
Kishimoto T: Interleukin-6: from basic
science to medicine – 40 years in immunology. Annu Rev Immunol.
23:1–21. 2005.
|
47
|
Wajant H, Pfizenmaier K and Scheurich P:
Tumor necrosis factor signaling. Cell Death Differ. 10:45–65. 2003.
View Article : Google Scholar : PubMed/NCBI
|
48
|
Coussens LM and Werb Z: Inflammatory cells
and cancer: think different! J Exp Med. 193:F23–F26. 2001.
|
49
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2001. View Article : Google Scholar
|
50
|
Zoltaszek R, Hanausek M, Slaga TJ and
Walaszek Z: Proapoptotic effects of D-glucarate on chemically
induced lung tumorigenesis in A/J mice. Proc Am Assoc Cancer Res.
48:7952007.
|
51
|
Zoltaszek R, Grzelak M, Hanausek M,
Kilianska Z, Slaga TJ and Walaszek Z: Effects of dietary
D-glucarate on biomarkers of inflammation during early
post-initiation stages of benzo[a]pyrene (B[a]P)-induced lung
tumorigenesis in A/J mice. Proc Am Assoc Cancer Res.
49:5322008.PubMed/NCBI
|
52
|
Rodriguez-Manzaneque JC, Lane TF, Ortega
MA, Hynes RO, Lawler J and Iruela-Arispe M: Thrombospondin-1
suppresses spontaneous tumor growth and inhibits activation of
matrix metalloproteinase-9 and mobilization of vascular endothelial
growth factor. PNAS USA. 98:12485–12490. 2001. View Article : Google Scholar
|
53
|
De Marzo AM, Marchi VL, Epstein JI and
Nelson WG: Proliferative inflammatory atrophy of the prostate:
implications for prostatic carcinogenesis. Am J Pathol.
155:1985–1992. 1999.PubMed/NCBI
|
54
|
Kuper H, Adami HO and Trichopoulos D:
Infections as a major preventable cause of human cancer. J Intern
Med. 248:171–173. 2000. View Article : Google Scholar : PubMed/NCBI
|
55
|
Baron JA and Sandler RS: Nonsteroidal
anti-inflammatory drugs and cancer prevention. Annu Rev Med.
51:511–523. 2000. View Article : Google Scholar : PubMed/NCBI
|
56
|
Williams CS, Mann M and DuBois RN: The
role of cyclooxygenases in inflammation, cancer, and development.
Oncogene. 18:7908–7916. 1999. View Article : Google Scholar : PubMed/NCBI
|
57
|
Di Carlo E, Forni G, Lollini P, Colombo
MP, Modesti A and Musiani P: The intriguing role of
polymorphonuclear neutrophils in anti-tumor reactions. Blood.
97:339–345. 2001.
|
58
|
Wahl LM and Kleinman HK: Tumor-associated
macrophages as targets for cancer therapy. J Natl Cancer Inst.
90:1583–1584. 1998. View Article : Google Scholar : PubMed/NCBI
|
59
|
Coussens LM, Raymond WW, Bergers G, et al:
Inflammatory mast cells up-regulate angiogenesis during squamous
epithelial carcinogenesis. Genes Dev. 13:1382–1397. 1999.
View Article : Google Scholar : PubMed/NCBI
|
60
|
Rothenberg ME: Eosinophilia. N Eng J Med.
338:1592–1600. 1998. View Article : Google Scholar : PubMed/NCBI
|
61
|
Gouon-Evans V, Rothenberg ME and Pollard
JW: Postnatal mammary gland development requires macrophages and
eosinophils. Development. 127:2269–2282. 2000.PubMed/NCBI
|
62
|
Lin EY, Nguyen AV, Russel RG and Pollard
JW: Colony-stimulating factor 1 promotes progression of mammary
tumors to malignancy. J Exp Med. 193:727–740. 2001. View Article : Google Scholar : PubMed/NCBI
|
63
|
Ono M, Torisu H, Fukushi J, Nishie A and
Kuwano M: Biological implications of macrophage infiltration in
human angiogenesis. Cancer Chemother Pharmacol. 43:S69–S71. 1999.
View Article : Google Scholar : PubMed/NCBI
|
64
|
Torisu H, Ono M, Kiryu H, Furue M, Ohmoto
Y, Nakayama J, Nishioka Y, Sone S and Kuwano M: Macrophage
infiltration correlates with tumor stage and angiogenesis in human
malignant melanoma: possible involvement of TNFalpha and IL-1alpha.
Int J Cancer. 85:182–188. 2000. View Article : Google Scholar
|
65
|
Coussens LM, Tinkel CL, Hanahan D and Werb
Z: MMP-9 supplied by bone marrow-derived cells contributes to skin
carcinogenesis. Cell. 103:481–490. 2000. View Article : Google Scholar : PubMed/NCBI
|
66
|
Walaszek Z, Hanausek-Walaszek M and Webb
TE: Dietary glucarate-mediated reduction of sensitivity of murine
strains to chemical carcinogenesis. Cancer Lett. 33:25–32. 1986.
View Article : Google Scholar : PubMed/NCBI
|
67
|
Gysin R, Azzi A and Visarius T:
Gamma-tocopherol inhibits human cancer cell cycle progression and
cell proliferation by down-regulation of cyclins. FASEB J.
16:1952–1954. 2002.PubMed/NCBI
|
68
|
Boivin D, Blanchette M, Barrette S,
Moghrabi A and Béliveau R: Inhibition of cancer cell proliferation
and suppression of TNF-induced activation of NFkappaB by edible
berry juice. Anticancer Res. 27:937–948. 2007.PubMed/NCBI
|